BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 18618341)

  • 1. A new fiducial marker for Image-guided radiotherapy of prostate cancer: clinical experience.
    Carl J; Nielsen J; Holmberg M; Højkjaer Larsen E; Fabrin K; Fisker RV
    Acta Oncol; 2008; 47(7):1358-66. PubMed ID: 18618341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical results from first use of prostate stent as fiducial for radiotherapy of prostate cancer.
    Carl J; Nielsen J; Holmberg M; Larsen EH; Fabrin K; Fisker RV
    Acta Oncol; 2011 May; 50(4):547-54. PubMed ID: 21174520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phantom and in-vivo measurements of dose exposure by image-guided radiotherapy (IGRT): MV portal images vs. kV portal images vs. cone-beam CT.
    Walter C; Boda-Heggemann J; Wertz H; Loeb I; Rahn A; Lohr F; Wenz F
    Radiother Oncol; 2007 Dec; 85(3):418-23. PubMed ID: 18023491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of geometric distortion in 0.2T MRI on radiotherapy treatment planning of prostate cancer.
    Petersch B; Bogner J; Fransson A; Lorang T; Pötter R
    Radiother Oncol; 2004 Apr; 71(1):55-64. PubMed ID: 15066296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of two image guided radiation therapy (IGRT) methods used for prostate cancer patients--CBCT and 2D-2D kV].
    Miszczyk L; Leszczyński W; Szczepanik K; Majewski W
    Przegl Lek; 2008; 65(7-8):315-20. PubMed ID: 19004227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance-based treatment planning for prostate intensity-modulated radiotherapy: creation of digitally reconstructed radiographs.
    Chen L; Nguyen TB; Jones E; Chen Z; Luo W; Wang L; Price RA; Pollack A; Ma CM
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):903-11. PubMed ID: 17544002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Patient positioning using in-room kV CT for image-guided radiotherapy (IGRT) of prostate cancer].
    Kliton J; Agoston P; Major T; Polgár C
    Magy Onkol; 2012 Sep; 56(3):193-8. PubMed ID: 23008828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment accuracy of fractionated stereotactic radiotherapy.
    Kumar S; Burke K; Nalder C; Jarrett P; Mubata C; A'hern R; Humphreys M; Bidmead M; Brada M
    Radiother Oncol; 2005 Jan; 74(1):53-9. PubMed ID: 15683670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance imaging in the radiation treatment planning of localized prostate cancer using intra-prostatic fiducial markers for computed tomography co-registration.
    Parker CC; Damyanovich A; Haycocks T; Haider M; Bayley A; Catton CN
    Radiother Oncol; 2003 Feb; 66(2):217-24. PubMed ID: 12648794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of fiducial marker-based position verification in the external beam radiotherapy of patients with prostate cancer.
    van der Heide UA; Kotte AN; Dehnad H; Hofman P; Lagenijk JJ; van Vulpen M
    Radiother Oncol; 2007 Jan; 82(1):38-45. PubMed ID: 17141903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A simulation of MRI based dose calculations on the basis of radiotherapy planning CT images.
    Eilertsen K; Vestad LN; Geier O; Skretting A
    Acta Oncol; 2008; 47(7):1294-302. PubMed ID: 18663645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical application of image-guided radiotherapy, IGRT (on the Varian OBI platform).
    Sorcini B; Tilikidis A
    Cancer Radiother; 2006 Sep; 10(5):252-7. PubMed ID: 16884940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of imaging modalities for image-guided radiation therapy (IGRT)].
    Kitamura K; Court LE; Dong L
    Nihon Igaku Hoshasen Gakkai Zasshi; 2003 Nov; 63(9):574-8. PubMed ID: 14699867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton therapy for prostate cancer treatment employing online image guidance and an action level threshold.
    Vargas C; Falchook A; Indelicato D; Yeung A; Henderson R; Olivier K; Keole S; Williams C; Li Z; Palta J
    Am J Clin Oncol; 2009 Apr; 32(2):180-6. PubMed ID: 19307953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility study using a Ni-Ti stent and electronic portal imaging to localize the prostate during radiotherapy.
    Carl J; Lund B; Larsen EH; Nielsen J
    Radiother Oncol; 2006 Feb; 78(2):199-206. PubMed ID: 16413623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost minimisation analysis: kilovoltage imaging with automated repositioning versus electronic portal imaging in image-guided radiotherapy for prostate cancer.
    Gill S; Younie S; Rolfo A; Thomas J; Siva S; Fox C; Kron T; Phillips D; Tai KH; Foroudi F
    Clin Oncol (R Coll Radiol); 2012 Oct; 24(8):e93-9. PubMed ID: 22694787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new lung stent tested as fiducial marker in a porcine model.
    Carl J; Nielsen J; Nielsen MS; Zepernick PR; Kjaergaard B; Jensen HK
    Radiother Oncol; 2012 Feb; 102(2):297-302. PubMed ID: 22192480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multimodality image fusion and planning and dose delivery for radiation therapy.
    Saw CB; Chen H; Beatty RE; Wagner H
    Med Dosim; 2008; 33(2):149-55. PubMed ID: 18456166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anatomy changes in radiotherapy detected using portal imaging.
    McDermott LN; Wendling M; Sonke JJ; van Herk M; Mijnheer BJ
    Radiother Oncol; 2006 May; 79(2):211-7. PubMed ID: 16698097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of manual and automatic MR-CT registration for radiotherapy of prostate cancer.
    Korsager AS; Carl J; Riis Østergaard L
    J Appl Clin Med Phys; 2016 May; 17(3):294-303. PubMed ID: 27167285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.